gli activation atypical protein kinase c iota/lambda regulates growth basal cell carcinomas
growth basal cell carcinomas bccs requires high levels hedgehog hh signalling transcription factor gli although inhibitors membrane protein smoothened smo effectively suppress hh signalling early tumour resistance illustrates need additional downstream targets therapy- identify atypical protein kinase c apkc-iota/lambda novel gli regulator mammals apkc-iota/lambda polarity signalling partners co-localize centrosome form complex missing-in-metastasis mim scaffolding protein potentiates hh signalling genetic pharmacological loss apkc-iota/lambda function blocks hh signalling proliferation bcc cells prkci hh target gene forms positive feedback loop gli exists increased levels bccs genome-wide transcriptional profiling shows apkc-iota/lambda smo control expression similar genes tumour cells apkc-iota/lambda functions downstream smo phosphorylate activate gli1 resulting maximal dna binding transcriptional activation activated apkc-iota/lambda upregulated smo-inhibitor-resistant tumours targeting apkc-iota/lambda suppresses signalling growth resistant bcc cell lines results demonstrate apkc-iota/lambda critical hh-dependent processes implicates apkc-iota/lambda new tumour-selective therapeutic target treatment smo-inhibitor-resistant cancers
[graphics]
